JD Supra

FDA Launches Pursuit of Fit-For-Purpose Regulatory Framework to Advance Rare Disease Drug Development

On October 14, 2026, the U.S. Food and Drug Administration (FDA) launched the Rare Disease Framework Initiative (“RDF Initiative”) to develop ...
Medical Xpress

FDA drug approval affects health care around the world, but political shortcuts could hurt the agency's reputation

At the beginning of July 2026, the U.S. Food and Drug Administration approved the first gene therapy for young children with sickle cell disease. While this is good news for children in the U.S. born ...